Accellacare - Wilmington - 1917 Tradd Court — Wilmington, North Carolina

Accellacare - Wilmington - 1917 Tradd Court is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Accellacare - Wilmington - 1917 Tradd Court has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD), Lower Respiratory Tract Illness.

Sponsors: Eli Lilly and Company, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in North Carolina · View every site in Wilmington

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare - Wilmington - 1917 Tradd Court?

Accellacare - Wilmington - 1917 Tradd Court has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare - Wilmington - 1917 Tradd Court conducted?

Accellacare - Wilmington - 1917 Tradd Court has 7 clinical trials on record, with 4 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD), Lower Respiratory Tract Illness.

Is Accellacare - Wilmington - 1917 Tradd Court accredited by Crixeo Clinical Trials?

Accellacare - Wilmington - 1917 Tradd Court has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accellacare - Wilmington - 1917 Tradd Court?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.